Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
University of Southern California
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
A Genome Wide Admixture Scan of Multiple Myeloma in African-Americans
ACTC AHEAD Alzheimer's Association Proposal: Diverse Recruitment Component
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (A3 Trial)
Alzheimer's Clinical Trials Consortium (ACTC) (U24)
Alzheimer's Disease Cooperative Study - A4 Study
Alzheimer's Disease Cooperative Study - A4 Study
Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes
Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease
Effects of Traumatic Brian Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans using ADNI
Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease
Global Alzheimer’s Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease
In-Home Obesity Prevention to Reach Low-Income Infants Through Maternal and Social Transmission
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study A Companion Observational Study to Antl-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Mechanistic Approaches to Inhibition of Emerging DNA Viruses
Small Molecule Inhibitors Targeting Adenovirus
Small Molecule Inhibitors Targeting Adenovirus
Small Molecule Inhibitors Targeting Adenovirus
Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve Clinical Trials Methods and Outcomes: Alzheimer Disease Clinical
Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)
The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease
The Polycomb System and Activity Levels During Aging: Establishing A Link in Humans